Page last updated: 2024-09-02

tryptoline and Parkinson Disease

tryptoline has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
López-Rivadulla Lamas, M; Méndez-Alvarez, E; Quiñoá-Cabana, E; Riguera-Vega, R; Sánchez-Sellero, I; Soto-Otero, R1
Cruz-Landeira, A; López-Rivadulla Lamas, M; Méndez-Alvarez, E; Sánchez-Sellero, I; Soto-Otero, R1

Other Studies

2 other study(ies) available for tryptoline and Parkinson Disease

ArticleYear
Studies on the interaction between 1,2,3,4-tetrahydro-beta-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease.
    Brain research, 1998, Aug-17, Volume: 802, Issue:1-2

    Topics: Animals; Brain; Carbolines; Drug Interactions; Gas Chromatography-Mass Spectrometry; Humans; Male; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Nicotiana; Parkinson Disease; Plants, Toxic; Rats; Rats, Sprague-Dawley; Smoke; Solutions

1998
Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke.
    Neuroscience letters, 2001, Feb-09, Volume: 298, Issue:3

    Topics: Animals; Brain; Carbolines; Dopamine; Isoquinolines; Male; Neurotoxins; Parkinson Disease; Rats; Rats, Sprague-Dawley; Smoking; Tetrahydroisoquinolines

2001